LEI 549300DR7KE3GRYREG06
Oxcia AB
Contract awards & public grants
Targeting OGG1 in Idiopathic Pulmonary Fibrosis → OXCIA AB
European Commission · SE · Grant · 2023-03-16
€2.5M
COmmercializing first-in-class dCTPase Inhibitors for treatment of hematological Cancers → OXCIA AB
European Commission · SE · Grant · 2015-12-22
€55,262
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.